{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:18:40Z","timestamp":1793330320377,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05559-4","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:20:04Z","timestamp":1781670004000},"page":"18619-18642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decoding polycystic ovary syndrome: an integrated review of epidemiology, molecular mechanisms, animal models, and the expanding therapeutic landscape"],"prefix":"10.1007","volume":"399","author":[{"given":"Ehab E.","family":"Sharata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Abdel-Samea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latifa Y.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maemona","family":"Mamdouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rabea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada H.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Abdelnaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham H.","family":"Mohyeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"4","key":"5559_CR1","first-page":"6995","volume":"8","author":"GO Adebodun","year":"2024","unstructured":"Adebodun GO, Dikne A, Egbeke A, Arikawe H, Bello B, Ekwobi K, Ogunsola AO (2024) Ameliorative potentials of Vernonia amygdalina in high-fat diet and letrozoleinduced polycystic ovary syndrome in female Wistar rats. Trop J Nat Prod Res 8(4):6995\u20139","journal-title":"Trop J Nat Prod Res"},{"issue":"9","key":"5559_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/ph18091291","volume":"18","author":"LN Al-Harbi","year":"2025","unstructured":"Al-Harbi LN, ALSedairy SA, Alshammari GM, Binobead MA, Arzoo S (2025) Protective effect of marjoram against letrozole-induced ovarian damage in rats with polycystic ovarian syndrome entails activation of Nrf2 and suppression of NF-\u03baB. Pharmaceuticals (Basel) 18(9):1291","journal-title":"Pharmaceuticals (Basel)"},{"issue":"13","key":"5559_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1080\/14656566.2016.1215430","volume":"17","author":"D Armanini","year":"2016","unstructured":"Armanini D, Andrisani A, Bordin L, Sabbadin C (2016) Spironolactone in the treatment of polycystic ovary syndrome. Expert Opin Pharmacother 17(13):1713\u20135","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"5559_CR4","first-page":"2434","volume":"85","author":"M Asunci\u00f3n","year":"2000","unstructured":"Asunci\u00f3n M, Calvo RM, San Mill\u00e1n JL, Sancho J, Avila S, Escobar-Morreale H (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85(7):2434\u20138","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5559_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez L, Knochenhauer E, Moran C, Lazenby J, Stephens K, Taylor K, Boots L (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89(2):453\u201362","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"5559_CR6","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1210\/jc.2005-0628","volume":"90","author":"R Azziz","year":"2005","unstructured":"Azziz R, Marin C, Hoq L, Badamgarav E, Song P (2005) Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab 90(8):4650\u20138","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"5559_CR7","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1093\/humrep\/dem108","volume":"22","author":"L Barnard","year":"2007","unstructured":"Barnard L, Ferriday D, Guenther N, Strauss B, Balen A, Dye L (2007) Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 22(8):2279\u201386","journal-title":"Hum Reprod"},{"key":"5559_CR8","doi-asserted-by":"crossref","unstructured":"Barber TM, Stephen F (2013) Genetics of polycystic ovary syndrome. eLS, 1\u20137","DOI":"10.1002\/9780470015902.a0026529"},{"issue":"9","key":"5559_CR9","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/humrep\/der197","volume":"26","author":"JA Barry","year":"2011","unstructured":"Barry JA, Kuczmierczyk AR, Hardiman PJ (2011) Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 26(9):2442\u201351","journal-title":"Hum Reprod"},{"key":"5559_CR10","doi-asserted-by":"crossref","unstructured":"Basheer M, Bhat AH, Hajam YA, Batiha GES, Ataya FS, Fouad D, Rai S (2023) Melatonin as a promising therapeutic intervention for restoring ovarian function in letrozole-induced polycystic ovary syndrome rats. Heliyon 9(11)","DOI":"10.1016\/j.heliyon.2023.e21237"},{"key":"5559_CR11","doi-asserted-by":"crossref","unstructured":"Binmahfouz LS, Bagher AM, Binmahfouz NS, Abdel-Naim AB, Shaik RA, Bangitah AA, ... Eid BG (2026) Galangin mitigates letrozole-induced polycystic ovary syndrome in rats by restoring PI3K\/pAKT\/PTEN signaling. Naunyn-Schmiedeberg's archives of pharmacology 1\u201315","DOI":"10.21203\/rs.3.rs-7979424\/v1"},{"issue":"6","key":"5559_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/humupd\/dml036","volume":"12","author":"C Boomsma","year":"2006","unstructured":"Boomsma C, Eijkemans M, Hughes E, Visser G, Fauser B, Macklon N (2006) A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 12(6):673\u201383","journal-title":"Hum Reprod Update"},{"issue":"12","key":"5559_CR13","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","volume":"31","author":"G Bozdag","year":"2016","unstructured":"Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 31(12):2841\u201355","journal-title":"Hum Reprod"},{"issue":"2","key":"5559_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","volume":"24","author":"MM Brzozowska","year":"2009","unstructured":"Brzozowska MM, Ostapowicz G, Weltman MD (2009) An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol 24(2):243\u20137","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"5559_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2265.1993.tb02150.x","volume":"38","author":"A Carey","year":"1993","unstructured":"Carey A, Chan K, Short F, White D, Williamson R, Franks S (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38(6):653\u20138","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"5559_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jgr.2019.08.007","volume":"44","author":"JH Choi","year":"2020","unstructured":"Choi JH, Jang M, Kim E-J, Lee MJ, Park KS, Kim S-H, In J-G, Kwak Y-S, Park D-H, Cho S-S (2020) Korean Red Ginseng alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats via its antiinflammatory and antioxidant activities. J Ginseng Res 44(6):790\u20138","journal-title":"J Ginseng Res"},{"issue":"5","key":"5559_CR17","doi-asserted-by":"publisher","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","volume":"288","author":"A Corbould","year":"2005","unstructured":"Corbould A, Kim Y-B, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A (2005) Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 288(5):E1047\u2013E54","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"5559_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, Griesinger G, Kelsey TW, La Marca A, Lambalk C (2014) The physiology and clinical utility of anti-M\u00fcllerian hormone in women. Hum Reprod Update 20(3):370\u201385","journal-title":"Hum Reprod Update"},{"issue":"6","key":"5559_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33(6):981\u20131030","journal-title":"Endocr Rev"},{"issue":"8","key":"5559_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.steroids.2013.04.009","volume":"78","author":"A Dokras","year":"2013","unstructured":"Dokras A (2013) Cardiovascular disease risk in women with PCOS. Steroids 78(8):773\u2013776","journal-title":"Steroids"},{"issue":"5","key":"5559_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS (2015) Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 36(5):487\u2013525","journal-title":"Endocr Rev"},{"issue":"6","key":"5559_CR22","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18(6):774\u2013800","journal-title":"Endocr Rev"},{"key":"5559_CR23","unstructured":"El Leithy AA, Al-Karmalawy AA, Youssif OM, Ebrahim YA, Khalifa AS, Elkaeed EB, Abo-Zeid FS (2022) Spirulina therapeutic potentiality in polycystic ovarian syndrome management using DHEA-induced rat model. European review for medical pharmacological sciences 26(8)"},{"issue":"1","key":"5559_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"B Fauser","year":"2004","unstructured":"Fauser B (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325","journal-title":"Fertil Steril"},{"issue":"2","key":"5559_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0026-0495(98)90213-X","volume":"47","author":"AM Fulghesu","year":"1998","unstructured":"Fulghesu AM, Ciampelli M, Guido M, Murgia F, Caruso A, Mancuso S, Lanzone A (1998) Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. Metabolism 47(2):158\u2013162","journal-title":"Metabolism"},{"issue":"1","key":"5559_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13048-020-00701-z","volume":"13","author":"Z Gao","year":"2020","unstructured":"Gao Z, Ma X, Liu J, Ge Y, Wang L, Fu P, Liu Z, Yao R, Yan X (2020) Troxerutin protects against DHT-induced polycystic ovary syndrome in rats. Journal of Ovarian Research 13(1):106","journal-title":"Journal of Ovarian Research"},{"issue":"11","key":"5559_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E (2015) American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1. Endocr Pract 21(11):1291\u20131300","journal-title":"Endocr Pract"},{"issue":"3","key":"5559_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1093\/humrep\/dem426","volume":"23","author":"Group TEA-SPCW","year":"2008","unstructured":"Group TEA-SPCW (2008) Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 23(3):462\u201377","journal-title":"Hum Reprod"},{"issue":"11","key":"5559_CR29","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.17305\/bb.2025.12676","volume":"25","author":"A\u00c7 G\u00fcndo\u011fdu","year":"2025","unstructured":"G\u00fcndo\u011fdu A\u00c7, Ar\u0131 NS, Ko\u00e7ak A, \u015eenol G, H\u00f6bel A, Eldiven \u00d6, Kar F, \u00d6zatik O (2025) Pirfenidone reduces ovarian fibrosis and improves PCOS in letrozole-induced rat model. Biomolecules and Biomedicine 25(11):2558","journal-title":"Biomolecules and Biomedicine"},{"issue":"1","key":"5559_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40738-016-0029-2","volume":"2","author":"HR Harris","year":"2016","unstructured":"Harris HR, Terry KL (2016) Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertility Research and Practice 2(1):14","journal-title":"Fertility Research and Practice"},{"key":"5559_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119558","volume":"283","author":"BAF Helal","year":"2021","unstructured":"Helal BAF, Ismail GM, Nassar SE, Zeid AAA (2021) Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats. Life Sci 283:119558","journal-title":"Life Sci"},{"issue":"3","key":"5559_CR32","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T (2021) Update on PCOS: consequences, challenges, and guiding treatment. J Clin Endocrinol Metab 106(3):e1071\u2013e83","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"5559_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/ijd.14370","volume":"58","author":"AC Hu","year":"2019","unstructured":"Hu AC, Chapman LW, Mesinkovska NA (2019) The efficacy and use of finasteride in women: a systematic review. Int J Dermatol 58(7):759\u201376","journal-title":"Int J Dermatol"},{"issue":"6","key":"5559_CR34","doi-asserted-by":"publisher","first-page":"E1085","DOI":"10.1152\/ajpendo.00034.2021","volume":"320","author":"Y Huang","year":"2021","unstructured":"Huang Y, Zhang X (2021) Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress. Am J Physiol Endocrinol Metab 320(6):E1085\u2013E92","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"5559_CR35","doi-asserted-by":"publisher","first-page":"838204","DOI":"10.3389\/fendo.2022.838204","volume":"13","author":"L Huang","year":"2022","unstructured":"Huang L, Liang A, Li T, Lei X, Chen X, Liao B, Tang J, Cao X, Chen G, Chen F (2022) Mogroside V improves follicular development and ovulation in young-adult PCOS rats induced by letrozole and high-fat diet through promoting glycolysis. Front Endocrinol 13:838204, 838204","journal-title":"Front Endocrinol"},{"issue":"4","key":"5559_CR36","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1017\/S0967199422000028","volume":"30","author":"AB Ismail","year":"2022","unstructured":"Ismail AB, Nebih \u0130, Tuncel G, Ozbakir B, Temel SG, Tulay P, Mocan G, Ergoren MC (2022) The expression profile of WNT\/\u03b2-catanin signalling genes in human oocytes obtained from polycystic ovarian syndrome (PCOS) patients. Zygote 30(4):536\u2013542","journal-title":"Zygote"},{"issue":"1","key":"5559_CR37","doi-asserted-by":"publisher","first-page":"34770","DOI":"10.1038\/s41598-025-18635-1","volume":"15","author":"M Jafari-Khorchani","year":"2025","unstructured":"Jafari-Khorchani M, Neisy A, Alaee S, Zare-Mehrjardi MJ, Zal F (2025) Quercetin modulates the interplay between DNMT gene expression, oxidative stress, and trace elements in DHEA-induced polycystic ovary syndrome rat model. Sci Rep 15(1):34770","journal-title":"Sci Rep"},{"issue":"3","key":"5559_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1530\/EJE-13-0797","volume":"170","author":"M Jensterle Sever","year":"2014","unstructured":"Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A (2014) Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin. Eur J Endocrinol 170(3):451\u20139","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"5559_CR39","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s43032-024-01503-0","volume":"31","author":"S Ji","year":"2024","unstructured":"Ji S, Yang H, Ji Y, Wu W, Dong Y, Fu H, Tang N, Hou Z, Wang F (2024) Liraglutide improves PCOS symptoms in rats by targeting FDX1. Reprod Sci 31(7):2049\u201358","journal-title":"Reprod Sci"},{"issue":"4","key":"5559_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/jwh.2014.5000","volume":"24","author":"AE Joham","year":"2015","unstructured":"Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J (2015) Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J Womens Health (2002) 24(4):299\u2013307","journal-title":"J Womens Health (2002)"},{"key":"5559_CR41","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1016\/j.fertnstert.2008.07.1277","volume":"90","author":"E Johnstone","year":"2008","unstructured":"Johnstone E, Shelly W, Mellon S, Cedars M (2008) Brain-derived neurotrophic factor is elevated in follicular fluid of women with PCOS. Fertil Steril 90:S256","journal-title":"Fertil Steril"},{"issue":"9","key":"5559_CR42","doi-asserted-by":"publisher","first-page":"5149","DOI":"10.1002\/fsn3.1819","volume":"8","author":"AM Kabel","year":"2020","unstructured":"Kabel AM, Ashour AM, Omar MS, Estfanous RS (2020) Effect of fish oil and telmisartan on dehydroepiandrosterone\u2010induced polycystic ovarian syndrome in rats: the role of oxidative stress, transforming growth factor beta\u20101, and nuclear factor kappa B. Food Sci Nutr 8(9):5149\u201359","journal-title":"Food Sci Nutr"},{"issue":"9","key":"5559_CR43","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/1440-1681.13698","volume":"49","author":"A Karimi","year":"2022","unstructured":"Karimi A, Tutunchi H, Naeini F, Vajdi M, Mobasseri M, Najafipour F (2022) The therapeutic effects and mechanisms of action of resveratrol on polycystic ovary syndrome: a comprehensive systematic review of clinical, animal and in vitro studies. Clin Exp Pharmacol Physiol 49(9):935\u201349","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"2","key":"5559_CR44","first-page":"107","volume":"66","author":"Z Khosrowpour","year":"2023","unstructured":"Khosrowpour Z, Fahimi S, Jafari F, Tansaz M, Sahranavard S, Faizi M (2023) Beneficial effects of Teucrium polium hydroalcoholic extract on letrozole-induced polycystic ovary syndrome in rat model. Obstet Gynecol Sci 66(2):107\u201317","journal-title":"Obstet Gynecol Sci"},{"issue":"9","key":"5559_CR45","first-page":"3078","volume":"83","author":"E Knochenhauer","year":"1998","unstructured":"Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83(9):3078\u201382","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5559_CR46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/uog.15898","volume":"48","author":"M Kollmann","year":"2016","unstructured":"Kollmann M, Martins W, Lima M, Craciunas L, Nastri C, Richardson A (2016) Strategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta\u2010analysis. Ultrasound Obstet Gynecol 48(6):709\u201318","journal-title":"Ultrasound Obstet Gynecol"},{"key":"5559_CR47","doi-asserted-by":"crossref","unstructured":"Lai H, Jia X, Yu Q, Zhang C, Qiao J, Guan Y, Kang J (2014) High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biol Reprod 91(5):127. 1\u201311","DOI":"10.1095\/biolreprod.114.120063"},{"issue":"9","key":"5559_CR48","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S (2013) Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod 28(9):2562\u20139","journal-title":"Hum Reprod"},{"issue":"5","key":"5559_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/1933719116667606","volume":"24","author":"T Li","year":"2017","unstructured":"Li T, Mo H, Chen W, Li L, Xiao Y, Zhang J, Li X, Lu Y (2017) Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci 24(5):646\u201355","journal-title":"Reprod Sci"},{"issue":"6","key":"5559_CR50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies M, Norman RJ, Moran L (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18(6):618\u201337","journal-title":"Hum Reprod Update"},{"key":"5559_CR51","doi-asserted-by":"publisher","first-page":"177870","DOI":"10.1016\/j.ejphar.2025.177870","volume":"1002","author":"Y Lin","year":"2025","unstructured":"Lin Y, Zhang Y, Ding X, Xu H, Xiong C, Tang M, Peng Y (2025) Chlorogenic acid mitigates DHEA-induced oxidative stress in granulosa cells and alleviates ferroptosis via the NF-\u03baB signaling pathway in PCOS. Eur J Pharmacol 1002:177870, 177870","journal-title":"Eur J Pharmacol"},{"key":"5559_CR52","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S484531","author":"M Liu","year":"2024","unstructured":"Liu M, Guo S, Li X, Tian Y, Yu Y, Tang L, Sun Q, Zhang T, Fan M, Zhang L (2024) Semaglutide alleviates ovary inflammation via the AMPK\/SIRT1\/NF\u2011\u03baB signaling pathway in polycystic ovary syndrome mice. Drug Des Devel Ther. https:\/\/doi.org\/10.2147\/DDDT.S484531","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"5559_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13048-025-01587-5","volume":"18","author":"H Liu","year":"2025","unstructured":"Liu H, Wang G, Sui C, Guo Y, He X (2025) Woxuanzhongzhou formula improves DHEAS and high-fat diet-induced IR and anovulatory mice via AMPK\/PGC1-\u03b1\/Irisin pathway. Journal of Ovarian Research 18(1):7","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"5559_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R (2016) Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril 106(1):6\u201315","journal-title":"Fertil Steril"},{"issue":"22","key":"5559_CR55","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15858","volume":"11","author":"MM Mahmoud","year":"2023","unstructured":"Mahmoud MM, Rashed LA, Soliman SA, Sayed SM, Kamel O, Kamar SS, Hussien RES (2023) SGLT-2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model. Physiol Rep 11(22):e15858","journal-title":"Physiol Rep"},{"issue":"3","key":"5559_CR56","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tem.2014.12.004","volume":"26","author":"JM McAllister","year":"2015","unstructured":"McAllister JM, Legro RS, Modi BP, Strauss JF (2015) Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol Metab 26(3):118\u201324","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"5559_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC (2016) Polycystic ovary syndrome. N Engl J Med 375(1):54\u201364","journal-title":"N Engl J Med"},{"issue":"12","key":"5559_CR58","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3109\/09513590.2014.943725","volume":"30","author":"N Mendoza","year":"2014","unstructured":"Mendoza N, Simoncini T, Genazzani AD (2014) Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies. Gynecol Endocrinol 30(12):850\u201360","journal-title":"Gynecol Endocrinol"},{"key":"5559_CR59","unstructured":"Mohammed F, Atef Zaaky I (2005) Effects of metformin on spontaneous and clomiphene-induced ovulattion in the polycystic ovary syndrome"},{"issue":"1","key":"5559_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/ijpvm.ijpvm_576_17","volume":"10","author":"M Mohammadi","year":"2019","unstructured":"Mohammadi M (2019) Oxidative stress and polycystic ovary syndrome: a brief review. Int J Prev Med 10(1):86","journal-title":"Int J Prev Med"},{"key":"5559_CR61","doi-asserted-by":"crossref","unstructured":"Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH (2017) Insulin\u2010sensitising drugs (metformin, rosiglitazone, pioglitazone, D\u2010chiro\u2010inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane database of systematic reviews (11)","DOI":"10.1002\/14651858.CD003053.pub6"},{"issue":"4","key":"5559_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"Moran LJ, Misso ML, Wild RA, Norman RJ (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 16(4):347\u201363","journal-title":"Hum Reprod Update"},{"issue":"10","key":"5559_CR63","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.1007\/s00210-024-03124-5","volume":"397","author":"PE Moustafa","year":"2024","unstructured":"Moustafa PE, Abo El Nasr NM, Shabana ME, Saleh DO (2024) Fisetin mitigates letrozole-induced polycystic ovarian syndrome in rats: crosstalk of AMPK\/PI3K\/AKT-mediated-Nrf2 antioxidant defense mechanism and the inflammasome NLRP3\/NF-\u03baB P65\/IL-1\u03b2 signaling pathways. Naunyn Schmiedebergs Arch Pharmacol 397(10):8077\u201388","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"5559_CR64","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s43032-025-01820-y","volume":"32","author":"MA Moustafa","year":"2025","unstructured":"Moustafa MA, Mohamed AS, Dakrory AI, Abdelaziz MH (2025) Lepidium sativum extract alleviates reproductive and developmental toxicity in polycystic ovary syndrome induced by letrozole and high-fat diet in rats. Reprod Sci 32(4):1338\u201361","journal-title":"Reprod Sci"},{"issue":"3","key":"5559_CR65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ram\u00edrez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 19(3):268\u201388","journal-title":"Hum Reprod Update"},{"issue":"2","key":"5559_CR66","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1038\/sj.ijo.0801282","volume":"24","author":"J Nestler","year":"2000","unstructured":"Nestler J (2000) Obesity, insulin, sex steroids and ovulation. Int J Obes 24(2):S71\u2013S3","journal-title":"Int J Obes"},{"issue":"5","key":"5559_CR67","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1007\/s00210-025-04705-8","volume":"399","author":"SG Niazi","year":"2026","unstructured":"Niazi SG, Saleem U, Hussain L, Saleem A (2026) Myricetin ameliorates letrozole-induced PCOS in female rats\u2014a mechanistic approach through in silico, in vitro, and in vivo study via P13\/AKT and NF-\u03baB pathway crosstalk. Naunyn Schmiedebergs Arch Pharmacol 399(5):6399\u2013428","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5559_CR68","doi-asserted-by":"crossref","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet 370(9588):685\u2013697","DOI":"10.1016\/S0140-6736(07)61345-2"},{"issue":"2","key":"5559_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/2305-0500.372379","volume":"12","author":"OT Olaniyan","year":"2023","unstructured":"Olaniyan OT, Dare A, Adetunji CO, Okotie GE, Dare JB, Adigun BM, Adebayo F (2023) Vitamin E modulates androgen receptor gene expression to attenuate ovarian dysfunctions in a rat model of dehydroepiandrosterone-induced polycystic ovary. Asian Pac J Reprod 12(2):81\u20139","journal-title":"Asian Pac J Reprod"},{"key":"5559_CR70","doi-asserted-by":"crossref","unstructured":"Olewi NZ, Hassan AF (2026) Possible protective effects of tirzepatide on polycystic ovary syndrome in female rat model induced by testosterone propionate in comparison to metformin. Naunyn-Schmiedeberg's archives of pharmacology 1-13","DOI":"10.1007\/s00210-026-05346-1"},{"issue":"9","key":"5559_CR71","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10815-016-0751-z","volume":"33","author":"P \u00d6zcan","year":"2016","unstructured":"\u00d6zcan P, F\u0131\u00e7\u0131c\u0131o\u011flu C, Kizilkale O, Yesiladali M, Tok OE, Ozkan F, Esrefoglu M (2016) Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage? J Assist Reprod Genet 33(9):1223\u20131230","journal-title":"J Assist Reprod Genet"},{"issue":"1","key":"5559_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio JF Jr (2009) Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 30(1):1\u201350","journal-title":"Endocr Rev"},{"issue":"1","key":"5559_CR73","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-020-02277-0","volume":"18","author":"A Paoli","year":"2020","unstructured":"Paoli A, Mancin L, Giacona MC, Bianco A, Caprio M (2020) Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med 18(1):104, 104","journal-title":"J Transl Med"},{"key":"5559_CR74","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.jep.2021.113947","volume":"273","author":"M-f Peng","year":"2021","unstructured":"Peng M-f, Tian S, Song Y-g, Li C-x, Miao M-s, Ren Z, Li M (2021) Effects of total flavonoids from Eucommia ulmoides Oliv. leaves on polycystic ovary syndrome with insulin resistance model rats induced by letrozole combined with a high-fat diet. J Ethnopharmacol 273:113947, 113947","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5559_CR75","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1080\/07853890.2022.2034933","volume":"54","author":"F Peng","year":"2022","unstructured":"Peng F, Hu Y, Peng S, Zeng N, Shi L (2022) Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis. Ann Med 54(1):578\u201387","journal-title":"Ann Med"},{"issue":"3","key":"5559_CR76","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.repbio.2020.05.004","volume":"20","author":"YD Prabhu","year":"2020","unstructured":"Prabhu YD, Gopalakrishnan AV (2020) \u03b3-Linolenic acid ameliorates DHEA induced pro-inflammatory response in polycystic ovary syndrome via PPAR-\u03b3 signaling in rats. Reprod Biol 20(3):348\u201356","journal-title":"Reprod Biol"},{"issue":"6","key":"5559_CR77","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1210\/jc.2011-0039","volume":"96","author":"J Puurunen","year":"2011","unstructured":"Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, J\u00e4rvel\u00e4 I, Ruokonen A, Tapanainen JS (2011) Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab 96(6):1827\u201334","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"5559_CR78","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/pathophysiology31040041","volume":"31","author":"D Rakic","year":"2024","unstructured":"Rakic D, Jakovljevic V, Zivkovic V, Jakovljevic Uzelac J, Jovic N, Muric M, Pindovic B, Dimitrijevic A, Arsenijevic P, Rakic J (2024) Multiple benefits of empagliflozin in pcos: evidence from a preclinical rat model. Pathophysiology 31(4):559\u2013582","journal-title":"Pathophysiology"},{"key":"5559_CR79","doi-asserted-by":"crossref","unstructured":"Ram K, Mehta NR, Patani P (2025) Pharmacological evaluation of psidium guajava leaf extract on a high-fat diet-induced polycystic ovary syndrome model in female rats. African journal of biomedical research 28","DOI":"10.53555\/AJBR.v28i2S.7536"},{"issue":"2","key":"5559_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.apjr.2016.01.006","volume":"5","author":"PS Reddy","year":"2016","unstructured":"Reddy PS, Begum N, Mutha S, Bakshi V (2016) Beneficial effect of curcumin in letrozole induced polycystic ovary syndrome. Asian Pac J Reprod 5(2):116\u201322","journal-title":"Asian Pac J Reprod"},{"issue":"5","key":"5559_CR81","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37(5):467\u2013520","journal-title":"Endocr Rev"},{"issue":"7","key":"5559_CR82","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B (2021) Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci 22(7):3789, 3789","journal-title":"Int J Mol Sci"},{"key":"5559_CR83","doi-asserted-by":"crossref","unstructured":"Seyam E, Al Gelany S, Abd Al Ghaney A, Mohamed MAA, Youseff AM, Ibrahim EM, ... Hefzy E (2018) Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome. Gynecological endocrinology 34(7)","DOI":"10.1080\/09513590.2017.1418853"},{"issue":"3","key":"5559_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/jog.70228","volume":"52","author":"KR Shirasath","year":"2026","unstructured":"Shirasath KR, Karwasra R, Ahmed NZ, Kumar P, Alam S, Goyal SN, Agrawal YO (2026) Protective effect of \u201cArk\u2010e\u2010Kasni,\u201d a Unani formulation, in letrozole and high\u2010fat diet\u2013induced polycystic ovarian syndrome in rats. J Obstet Gynaecol Res 52(3):e70228","journal-title":"J Obstet Gynaecol Res"},{"key":"5559_CR85","doi-asserted-by":"publisher","first-page":"105977","DOI":"10.1016\/j.jsbmb.2021.105977","volume":"214","author":"S Shirooie","year":"2021","unstructured":"Shirooie S, Khaledi E, Dehpour AR, Noori T, Khazaei M, Sadeghi F, Sobarzo-Sanchez E (2021) The effect of dapsone in testosterone enanthate-induced polycystic ovary syndrome in rat. J Steroid Biochem Mol Biol 214:105977, 105977","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"5559_CR86","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1007\/s10787-025-01809-8","volume":"33","author":"A Siddiqua","year":"2025","unstructured":"Siddiqua A, Malik A, Iqbal U, Sial NT, Mehmood MH, Rehman M (2025) Antioxidative and anti-inflammatory effects of Carvacrol against polycystic ovary syndrome associated complications using high fat diet and Letrozole challenged rat model: a multidisciplinary study cascading in vivo, in vitro, in silico and network pharmacology approaches. Inflammopharmacology 33(8):4703\u201324","journal-title":"Inflammopharmacology"},{"issue":"2","key":"5559_CR87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29(2):181\u201391","journal-title":"Am J Obstet Gynecol"},{"key":"5559_CR88","doi-asserted-by":"publisher","first-page":"1142041","DOI":"10.3389\/fcimb.2023.1142041","volume":"13","author":"Y Sun","year":"2023","unstructured":"Sun Y, Gao S, Ye C, Zhao W (2023) Gut microbiota dysbiosis in polycystic ovary syndrome: mechanisms of progression and clinical applications. Front Cell Infect Microbiol 13:1142041, 1142041","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"5559_CR89","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1933719117711262","volume":"25","author":"V Tagliaferri","year":"2018","unstructured":"Tagliaferri V, Romualdi D, Scarinci E, Cicco SD, Florio CD, Immediata V, Tropea A, Santarsiero CM, Lanzone A, Apa R (2018) Melatonin treatment may be able to restore menstrual cyclicity in women with PCOS: a pilot study. Reprod Sci 25(2):269\u201375","journal-title":"Reprod Sci"},{"issue":"9","key":"5559_CR90","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ (2018) Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod 33(9):1602\u201318","journal-title":"Hum Reprod"},{"issue":"1","key":"5559_CR91","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","volume":"79","author":"K Tremellen","year":"2012","unstructured":"Tremellen K, Pearce K (2012) Dysbiosis of gut microbiota (DOGMA)\u2013a novel theory for the development of polycystic ovarian syndrome. Med Hypotheses 79(1):104\u201312","journal-title":"Med Hypotheses"},{"key":"5559_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121380","volume":"315","author":"NB T\u00fcrkmen","year":"2023","unstructured":"T\u00fcrkmen NB, Y\u00fcce H, Ayd\u0131n M, Ta\u015fl\u0131dere A, Do\u011fan A, \u00d6zek DA, Hayal TB, Ya\u015far \u015e, \u00c7ift\u00e7i O, \u00dcn\u00fcvar S (2023) Nerolidol attenuates dehydroepiandrosterone-induced polycystic ovary syndrome in rats by regulating oxidative stress and decreasing apoptosis. Life Sci 315:121380","journal-title":"Life Sci"},{"key":"5559_CR93","doi-asserted-by":"crossref","unstructured":"ul haq Shah MZ, Shrivastava V, Mir MA (2022) Metformin treatment ameliorates endocrine-metabolic disturbances in letrozole-induced PCOS mice model by modulating adiponectin status. Obes Med 31:100392","DOI":"10.1016\/j.obmed.2022.100392"},{"issue":"1","key":"5559_CR94","first-page":"1849162","volume":"2016","author":"V Unfer","year":"2016","unstructured":"Unfer V, Nestler JE, Kamenov ZA, Prapas N, Facchinetti F (2016) Effects of inositol (s) in women with PCOS: a systematic review of randomized controlled trials. Int J Endocrinol 2016(1):1849162","journal-title":"Int J Endocrinol"},{"key":"5559_CR95","doi-asserted-by":"crossref","unstructured":"Webber L, Stubbs S, Stark J, Trew G, Margara R, Hardy K, Franks S (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362(9389):1017\u20131021","DOI":"10.1016\/S0140-6736(03)14410-8"},{"issue":"5","key":"5559_CR96","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","volume":"95","author":"RA Wild","year":"2010","unstructured":"Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 95(5):2038\u201349","journal-title":"J Clin Endocrinol Metab"},{"key":"5559_CR97","doi-asserted-by":"publisher","first-page":"170624","DOI":"10.1016\/j.peptides.2021.170624","volume":"145","author":"L-m Wu","year":"2021","unstructured":"Wu L-m, Wang Y-x, Zhan Y, Liu A-h, Wang Y-x, Shen H-f, Wang Y-f, Wang L-y, Tao Z-b, Wang Y-q (2021) Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats. Peptides 145:170624","journal-title":"Peptides"},{"issue":"1","key":"5559_CR98","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12905-024-03445-w","volume":"24","author":"H Xu","year":"2024","unstructured":"Xu H, Qiu S, Lin P, Liao X, Lin Y, Sun Y, Zheng B (2024) Vitamin D has therapeutic effects on obesity and hyperandrogenemia in PCOS mouse model induced by low dose DHEA and high-fat diet. BMC Womens Health 24(1):601","journal-title":"BMC Womens Health"},{"issue":"28","key":"5559_CR99","doi-asserted-by":"publisher","first-page":"24831","DOI":"10.1021\/acsomega.3c00578","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang J, Wang E, Chen W, Xu B, Chen C, Zhang G, Yao J (2023) TMT-based proteomics analysis of the intervention effect of orlistat on polycystic ovary syndrome rats induced by letrozole combined with a high-fat diet. ACS Omega 8(28):24831\u201324840","journal-title":"ACS Omega"},{"issue":"5","key":"5559_CR100","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/jog.14730","volume":"47","author":"J Yu","year":"2021","unstructured":"Yu J, Ding C, Hua Z, Jiang X, Wang C (2021) Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K\/AKT pathway. J Obstet Gynaecol Res 47(5):1789\u2013803","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"5559_CR101","doi-asserted-by":"publisher","first-page":"2183045","DOI":"10.1080\/09513590.2023.2183045","volume":"39","author":"F Yu","year":"2023","unstructured":"Yu F, Xue Y, Zhao Y, Zhang L, He X, Liu Z (2023) Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats. Gynecol Endocrinol 39(1):2183045, 2183045","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"5559_CR102","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/07315724.2019.1657515","volume":"39","author":"G Yurtda\u015f","year":"2020","unstructured":"Yurtda\u015f G, Akdevelio\u011flu Y (2020) A new approach to polycystic ovary syndrome: the gut microbiota. J Am Coll Nutr 39(4):371\u201382","journal-title":"J Am Coll Nutr"},{"key":"5559_CR103","unstructured":"Zawadri J (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic ovary syndrome. Current issues in endocrinology and metabolism"},{"issue":"4","key":"5559_CR104","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/REP-15-0542","volume":"151","author":"H Zhang","year":"2016","unstructured":"Zhang H, Yi M, Zhang Y, Jin H, Zhang W, Yang J, Yan L, Li R, Zhao Y, Qiao J (2016) High-fat diets exaggerate endocrine and metabolic phenotypes in a rat model of DHEA-induced PCOS. Reproduction 151(4):431\u2013441","journal-title":"Reproduction"},{"issue":"19","key":"5559_CR105","doi-asserted-by":"publisher","first-page":"5584","DOI":"10.3390\/jcm11195584","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen D, Wang D, Wang L, Weng Y, Wang H, Wu X, Wang Y (2022) Moderate aerobic exercise regulates follicular dysfunction by initiating brain-derived neurotrophic factor (BDNF)-mediated anti-apoptotic signaling pathways in polycystic ovary syndrome. J Clin Med 11(19):5584, 5584","journal-title":"J Clin Med"},{"issue":"1","key":"5559_CR106","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13048-024-01554-6","volume":"17","author":"F Zhao","year":"2024","unstructured":"Zhao F, Cui W, Fang C, Luo Y, Zhang C (2024) Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats. J Ovarian Res 17(1):229, 229","journal-title":"J Ovarian Res"},{"issue":"1","key":"5559_CR107","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13048-021-00912-y","volume":"14","author":"B Zheng","year":"2021","unstructured":"Zheng B, Meng J, Zhu Y, Ding M, Zhang Y, Zhou J (2021) Melatonin enhances SIRT1 to ameliorate mitochondrial membrane damage by activating PDK1\/Akt in granulosa cells of PCOS. J Ovarian Res 14(1):152","journal-title":"J Ovarian Res"},{"key":"5559_CR108","doi-asserted-by":"publisher","first-page":"175825","DOI":"10.1016\/j.ejphar.2023.175825","volume":"953","author":"L Zuo","year":"2023","unstructured":"Zuo L, Hai Y, Zhang R, Zuo B, Tian J, Li P, Ke X, Wang M, Ren L, Li X (2023) Therapeutic potential of icariin in rats with letrozole and high-fat diet-induced polycystic ovary syndrome. Eur J Pharmacol 953:175825, 175825","journal-title":"Eur J Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05559-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:02:36Z","timestamp":1791540156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05559-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5559"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05559-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}